Alloutcoach Tim

STATE OF INVESTMENT AND INNOVATION IN HEALTHCARE: 2025 Financial Times US Pharma Summit

Informações:

Sinopsis

On this episode of Alloutcoach, host Tim Mikhelashvili, CEO, Amedea Pharma convenes a panel you rarely hear in one room: a policy-minded biohacker and investor (John Hemming, CEO of Cirrostratus, Biohacking Team Leader), a strategy and operations leader who reshapes patient journeys (Bart Zoni, Senior Vice President, Marketing, Woven Health Collective), and an early-stage investor focused on medical technologies (Chris Piedmonte, Managing Director, Neoterra Capital) as well as a senior pharma thought leader in Medical Affairs and Health Economics, Janelle Hardisty. Their catalyst? Fresh takeaways from the 2025 Financial Times US Pharma summit — and an honest look at what’s truly accelerating innovation, what’s stalling it, and where capital and talent should go next.00:00:00 Cold Open - Episode Highlights: AI accuracy and access00:03:43 Host Intro and Why This Episode00:04:41 Guest Intros00:08:06 State of Innovation - Tailwinds and Headwinds00:12:41 What’s Really Accelerating Innovation?00:19:27 Drug Discover